Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_assertion type Assertion NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_head.
- NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_assertion description "[JAK1/2 inhibitors have broadened the therapeutic options in myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_provenance.
- NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_assertion evidence source_evidence_literature NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_provenance.
- NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_assertion SIO_000772 25189727 NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_provenance.
- NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_assertion wasDerivedFrom befree-2016 NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_provenance.
- NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_assertion wasGeneratedBy ECO_0000203 NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_provenance.